BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

449 related articles for article (PubMed ID: 23133552)

  • 1. Modulation of the osteosarcoma expression phenotype by microRNAs.
    Namløs HM; Meza-Zepeda LA; Barøy T; Østensen IH; Kresse SH; Kuijjer ML; Serra M; Bürger H; Cleton-Jansen AM; Myklebost O
    PLoS One; 2012; 7(10):e48086. PubMed ID: 23133552
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MiR-133b is down-regulated in human osteosarcoma and inhibits osteosarcoma cells proliferation, migration and invasion, and promotes apoptosis.
    Zhao H; Li M; Li L; Yang X; Lan G; Zhang Y
    PLoS One; 2013; 8(12):e83571. PubMed ID: 24391788
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Microarray Expression Profile and Functional Analysis of Circular RNAs in Osteosarcoma.
    Liu W; Zhang J; Zou C; Xie X; Wang Y; Wang B; Zhao Z; Tu J; Wang X; Li H; Shen J; Yin J
    Cell Physiol Biochem; 2017; 43(3):969-985. PubMed ID: 28957794
    [TBL] [Abstract][Full Text] [Related]  

  • 4. RNA Sequencing of Osteosarcoma Gene Expression Profile Revealed that miR-214-3p Facilitates Osteosarcoma Cell Proliferation via Targeting Ubiquinol-Cytochrome c Reductase Core Protein 1 (UQCRC1).
    Zhao X; Wang Q; Lin F; Wang X; Wang Y; Wang J; Wang C
    Med Sci Monit; 2019 Jul; 25():4982-4991. PubMed ID: 31276465
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MiR-9 is overexpressed in spontaneous canine osteosarcoma and promotes a metastatic phenotype including invasion and migration in osteoblasts and osteosarcoma cell lines.
    Fenger JM; Roberts RD; Iwenofu OH; Bear MD; Zhang X; Couto JI; Modiano JF; Kisseberth WC; London CA
    BMC Cancer; 2016 Oct; 16(1):784. PubMed ID: 27724924
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MicroRNA profiling reveals dysregulated microRNAs and their target gene regulatory networks in cemento-ossifying fibroma.
    Pereira TDSF; Brito JAR; Guimarães ALS; Gomes CC; de Lacerda JCT; de Castro WH; Coimbra RS; Diniz MG; Gomez RS
    J Oral Pathol Med; 2018 Jan; 47(1):78-85. PubMed ID: 29032608
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genetic and molecular characterization of the human osteosarcoma 3AB-OS cancer stem cell line: a possible model for studying osteosarcoma origin and stemness.
    Di Fiore R; Fanale D; Drago-Ferrante R; Chiaradonna F; Giuliano M; De Blasio A; Amodeo V; Corsini LR; Bazan V; Tesoriere G; Vento R; Russo A
    J Cell Physiol; 2013 Jun; 228(6):1189-201. PubMed ID: 23129384
    [TBL] [Abstract][Full Text] [Related]  

  • 8. LncRNA MEG3 negatively modified osteosarcoma development through regulation of miR-361-5p and FoxM1.
    Shen B; Zhou N; Hu T; Zhao W; Wu D; Wang S
    J Cell Physiol; 2019 Aug; 234(8):13464-13480. PubMed ID: 30624782
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MicroRNA-199a-3p is downregulated in human osteosarcoma and regulates cell proliferation and migration.
    Duan Z; Choy E; Harmon D; Liu X; Susa M; Mankin H; Hornicek F
    Mol Cancer Ther; 2011 Aug; 10(8):1337-45. PubMed ID: 21666078
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MicroRNA-196a overexpression promotes cell proliferation and inhibits cell apoptosis through PTEN/Akt/FOXO1 pathway.
    Shang Y; Wang LQ; Guo QY; Shi TL
    Int J Clin Exp Pathol; 2015; 8(3):2461-72. PubMed ID: 26045752
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Construction of microRNA-messenger networks for human osteosarcoma.
    Ma G; Zhang C; Luo W; Zhao JL; Wang X; Qian Y
    J Cell Physiol; 2019 Aug; 234(8):14145-14153. PubMed ID: 30666640
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of miRNA-542-5p in the tumorigenesis of osteosarcoma.
    Zhu T; Fan D; Ye K; Liu B; Cui Z; Liu Z; Tian Y
    FEBS Open Bio; 2020 Apr; 10(4):627-636. PubMed ID: 32105410
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Functional characterisation of osteosarcoma cell lines and identification of mRNAs and miRNAs associated with aggressive cancer phenotypes.
    Lauvrak SU; Munthe E; Kresse SH; Stratford EW; Namløs HM; Meza-Zepeda LA; Myklebost O
    Br J Cancer; 2013 Oct; 109(8):2228-36. PubMed ID: 24064976
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long Non-Coding RNA TUG1 Promotes Proliferation and Inhibits Apoptosis of Osteosarcoma Cells by Sponging miR-132-3p and Upregulating SOX4 Expression.
    Li G; Liu K; Du X
    Yonsei Med J; 2018 Mar; 59(2):226-235. PubMed ID: 29436190
    [TBL] [Abstract][Full Text] [Related]  

  • 15. miRNA profiling identifies deregulated miRNAs associated with osteosarcoma development and time to metastasis in two large cohorts.
    Andersen GB; Knudsen A; Hager H; Hansen LL; Tost J
    Mol Oncol; 2018 Jan; 12(1):114-131. PubMed ID: 29120535
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Screening and Analysis of Biomarkers in the miRNA-mRNA Regulatory Network of Osteosarcoma.
    Han G; Guo Q; Li N; Bi W; Xu M; Jia J
    J Healthc Eng; 2022; 2022():8055052. PubMed ID: 35340229
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oral squamous cell carcinoma: microRNA expression profiling and integrative analyses for elucidation of tumourigenesis mechanism.
    Manikandan M; Deva Magendhra Rao AK; Arunkumar G; Manickavasagam M; Rajkumar KS; Rajaraman R; Munirajan AK
    Mol Cancer; 2016 Apr; 15():28. PubMed ID: 27056547
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CircMYO10 promotes osteosarcoma progression by regulating miR-370-3p/RUVBL1 axis to enhance the transcriptional activity of β-catenin/LEF1 complex via effects on chromatin remodeling.
    Chen J; Liu G; Wu Y; Ma J; Wu H; Xie Z; Chen S; Yang Y; Wang S; Shen P; Fang Y; Fan S; Shen S; Fang X
    Mol Cancer; 2019 Oct; 18(1):150. PubMed ID: 31665067
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MicroRNA-199b-5p is involved in the Notch signaling pathway in osteosarcoma.
    Won KY; Kim YW; Kim HS; Lee SK; Jung WW; Park YK
    Hum Pathol; 2013 Aug; 44(8):1648-55. PubMed ID: 23574781
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential expression profiles of microRNAs as potential biomarkers for the early diagnosis of lung cancer.
    Zhang Y; Sui J; Shen X; Li C; Yao W; Hong W; Peng H; Pu Y; Yin L; Liang G
    Oncol Rep; 2017 Jun; 37(6):3543-3553. PubMed ID: 28498428
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.